EHR algorithm can be used to detect, classify diabetes

EHR algorithm can be used to detect, classify diabetes
Data from electronic health records can be used to detect more cases of diabetes than claim codes alone and can be used to accurately distinguish between type 1 and type 2 diabetes, according to a study published online Nov. 27 in Diabetes Care.

(HealthDay)—Data from electronic health records (EHRs) can be used to detect more cases of diabetes than claim codes alone and can be used to accurately distinguish between type 1 and type 2 diabetes, according to a study published online Nov. 27 in Diabetes Care.

To classify type 1 versus type 2 disease, Michael Klompas, M.D., M.P.H., of Harvard Medical School and the Harvard Pilgrim Health Care Institute in Boston, and colleagues used four years of structured EHR data, such as laboratory test results, diagnosis codes, and suggestive prescriptions, from a large, multispecialty ambulatory practice serving approximately 700,000 patients. The optimized algorithm was tested in a cohort of 210 patients and validated in an additional cohort.

The researchers found that the algorithm flagged 43,177 patients. For type 1 diabetes, the sensitivity and of the International Classification of Diseases version 9 codes were 26 and 94 percent, respectively, for type 1 codes alone, and 90 and 57 percent, respectively, for two or more type 1 codes and any number of type 2 codes. Using an optimized algorithm incorporating the ratio of these codes plus additional information on plasma C-peptide and autoantibody levels and suggestive prescriptions, 100 percent of patients with type 1 diabetes were flagged. On validation, the optimized algorithm correctly identified 35 of 36 patients with .

"In sum, we demonstrate the utility of EHR-based algorithms to detect and classify patients with diabetes," the authors write.

One author is an employee of Heliotropic Inc.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Cataract risk up for statin users with type 2 diabetes

Aug 13, 2012

(HealthDay) -- Statin use, which is substantially higher in patients with type 2 diabetes, correlates with an increased risk of age-related (AR) cataracts, according to a study published in the August issue ...

Lung cancer risk unaffected by metformin use in diabetes

Aug 30, 2012

(HealthDay)—Patients with type 2 diabetes who take metformin do not have a reduced risk of lung cancer, in contrast to previous observational studies, according to a study published online Aug. 24 in Diabetes Care.

Recommended for you

Added fructose is a principal driver of type 2 diabetes

Jan 29, 2015

Recent studies have shown that added sugars, particularly those containing fructose, are a principal driver of diabetes and pre-diabetes, even more so than other carbohydrates. Clinical experts writing in Mayo Clinic Proceedings challe ...

Support found for peer-mentoring diabetes management program

Jan 29, 2015

Managing type 1 diabetes is a never-ending task that requires multiple blood glucose tests, carbohydrate calculations and insulin injections or infusions. This constant effort to control the disease is daunting at any age ...

How does DPP-4 inhibition affect liver function?

Jan 27, 2015

(HealthDay)—Dipeptidyl peptidase-4 (DPP-4) inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet (WD) through hepatic lipid remodeling and modulation of hepatic mitochondrial ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.